Latest Breaking News On - Richard mollard - Page 1 : comparemela.com

Plymouth Raiders collapse probed after club went bust leaving debts of £800k

Plymouth Raiders collapse probed after club went bust leaving debts of £800k
plymouthherald.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plymouthherald.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomRoss mackenzieRichard mollardPlymouth city councilBritish basketball leagueCollege sports ltdCollege sportsDepartment for businessPlymouth raiders basketball clubCompanies houseBcollege ltdCowgill holloway business recoveryPlymouth raidersSport englandIndustrial strategyCompany director disqualification act

PharmAust focuses in on monepantel trials for motor neurone disease and canine cancer

Perth-based biotech PharmAust (ASX: PAA) has posted a June quarter of activities heavily focused on the effects of primary drug candidate monepantel on patients with motor neurone disease.

Western australiaFiona milnerRichard mollardAlithia life sciencesEuropean unionNational energy resources australiaDrug administrationWa school of mines curtin universityGood manufacturing practiceCurtin university

New clinical trial to test cancer drug in motor neuron disease

New clinical trial to test cancer drug in motor neuron disease
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Richard mollardAmyotrophic lateralAustralian fightBig freeze

PharmAust says MPL tablets arrive for Motor Neuron Disease trial

PharmAust says MPL tablets arrive for Motor Neuron Disease trial
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Richard mollardGood manufacturing practice

PharmAust latest report gives green light for continuing trials

PharmAust (ASX: PAA) has announced the company is adequately funded to continue its current activities after releasing its March quarter (Q3 FY22) report this week.

United statesWestern australiaNew zealandRichard mollardUnited ergomed clinical researchAlithia life sciencesGood manufacturing practiceUnited kingdom based ergomed clinical research